Externalizing traits have been related with the outcomes of coronavirus disease 2019
(COVID-19) and Alzheimer's dementia (AD); however, whether these associations are …

COVID-19 has put vaccine efficacy under a spotlight. However, the reluctance of people to
be vaccinated has postponed the end of the COVID-19 pandemic. Currently, opioid vaccines …

The objectives of this study were to 1) identify vaccination rates among PWID in Oregon at a
time when vaccines were easily accessible, 2) quantitatively identify convergence with …

Background Population-level statistics on pandemic-related change in substance use can
obscure patterns of use (eg, polysubstance use) within individuals. This longitudinal study …

Background There is limited evidence quantifying the risk of severe COVID-19 disease
among people with opioid dependence. We examined vaccine uptake and severe disease …

Background While cannabis is known to have immunomodulatory properties, the clinical
consequences of its use on outcomes in COVID-19 have not been extensively evaluated …

Patients with major psychiatric disorders (MPD) that include schizophrenia (SCH), bipolar
disorder (BP), and major depressive disorder (MDD) are at increased risk for coronavirus …

Vaccines against severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2)
infection, which causes coronavirus disease–19 (COVID-19) in humans, have been …

The Article by Caige Huang and colleagues1 published in The Lancet Psychiatry contributes
to the literature on the effectiveness of COVID-19 vaccines during the global pandemic. The …

Background: Given the important implications of youth substance use, it is essential to
document and describe changes in substance use during the coronavirus disease 2019 …